March 19, 2013 — Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
March 19, 2013
March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the company ...
March 13, 2013
February 25, 2013 — The U.S. Food and Drug Administration (FDA) granted final approval for the Biotronik Lumax 740 DX ...
February 25, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature | Dave Fornell
To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on ...
January 29, 2013
January 21, 2013 — The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to ...
January 21, 2013
January 21, 2013 — At the Boston Atrial Fibrillation (AF) Symposium 2013, Philips Healthcare introduced its latest ...
January 21, 2013Sponsored Content
Blog
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
November 13, 2023
January 18, 2013 — nContact Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s ...
January 18, 2013
January 8, 2013 — The results of a recent study presented yesterday at the American Heart Association Scientific ...
January 08, 2013
November 15, 2012 — The U.S. Patent and Trademark Office has awarded Biomedical Systems U.S. Patent Number 8301236 for ...
November 15, 2012Sponsored Content
Blog
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
November 02, 2023November 9, 2012 — Bristol-Myers Squibb Co. and Pfizer Inc. announced that the reductions in stroke or systemic embolism ...
November 09, 2012
October 8, 2012 — The U.S. Food and Drug Administration (FDA) has granted Clinical Laboratory Improvement Amendments ...
October 08, 2012October 2, 2012 — A novel blood thinner recently approved by the U.S. Food and Drug Administration (FDA), Pradaxa ...
October 02, 2012Sponsored Content
Blog | ECG
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 24, 2022
October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA ...
October 01, 2012September 19, 2012 — This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to ...
September 19, 2012September 13, 2012 — Janssen Research & Development LLC announced that it has submitted the complete response to the U.S ...
September 13, 2012